The increasing ability for a wide variety of microorganisms to resist efforts to control them is a global health problem that must be proactively combated by medical practitioners around the world to avoid a global health catastrophe.
Antimicrobial resistance (AMR) refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of drugs that were previously effective in treating infections caused by these microorganisms.
When microorganisms become resistant to antibacterial, antifungal, antiviral, or antiparasitic chemical agents, these drugs are no longer able to kill or control the growth of these organisms. The inability to control these infections can lead to longer illnesses, more severe symptoms, and even death. AMR is a threat to global public health, with implications regardless of age, gender, or geographic location.
One of the main drivers of AMR is the overuse and misuse of antimicrobial drugs, such as antibiotics. When these drugs are used too often or inappropriately, microorganisms can become resistant to them over time through genetic mutations or the transfer of resistance genes from one microorganism to another.
Antimicrobial resistance occurs when a bacteria, fungi, virus, or parasite is stronger than the antibiotic, antifungal, antiviral, or antiparasitic agent designed to control it or kill it.
Antimicrobials are the term for a variety of substances that are used to kill or inhibit the growth of microorganisms, such as bacteria, viruses, fungi, and parasites. They can be classified into several categories, including antibiotics, antivirals, antifungals, and antiparasitics.
These are just a few examples of the many different types of antimicrobials available. It's important to note that not all antimicrobials are effective against all types of microorganisms. The overuse and misuse of these drugs is a major contributing factor toward general antimicrobial resistance:
penicillin, amoxicillin, erythromycin, and ciprofloxacin
acyclovir, oseltamivir, and remdesivir
fluconazole, ketoconazole, and itraconazole
chloroquine, mebendazole, and ivermectin
bleach, hydrogen peroxide, and alcohol
iodine, chlorhexidine, and hydrogen peroxide
In order to achieve optimal global health, all people, animals, plants, and ecosystems must have the resources they need to ensure proper sanitation and hygiene while practicing appropriate methods for distributing and taking antibiotics and antifungals. Without inclusive proper health measures, there will be negative effects on public health, food security, and economic development.
If AMR continues to negatively affect global health, there will be a great impact on the productivity of national economies and their health systems. Effective prevention and tools are the only answer to AMR’s destruction.
Here are just a few examples of the diseases and conditions that can be impacted by antimicrobial resistance. It's important to use antimicrobial drugs judiciously to help preserve their effectiveness in treating infectious diseases.
Since their invention, germs have been evolving to build a tolerance against the antimicrobial drugs. When the same antimicrobial is overused in humans or animals, the parasite, disease, or virus isn’t as strongly affected or killed off due to this built up tolerance. Over time, this results in antimicrobial resistance as germs are not effectively killed when combated with antimicrobials.
Addressing antimicrobial resistance is key to improving global health. One of our core missions at Biomeme is the pursuit of One Health, the concept of a collaborative approach to communal, regional, national, and global levels, that all parts of an existing ecosystem are equal and must be healthy at each level to be sustainable. Combating antimicrobial resistance and pursuing One Health are inextricably linked.
That is why we advocate strongly for the responsible, discerning use of antimicrobials and antibiotics as the first fundamental step that healthcare providers must take when prescribing solutions to patients. We also know that giving communities the help, resources, and education they need to use their best judgment is key. We provide information and solutions for the overuse and misuse of antimicrobials so that populations can make the most educated decisions regarding their defense measures against infectious diseases and catastrophic health issues.
And we offer defense against the world’s most detrimental infectious diseases with real-time, rapid testing solutions to take the proactive steps needed to stay ahead of AMR. Our Host Response Test (HR-B/V) offers the reliable, detailed results practitioners need to determine a viral or bacterial infection, offering them the data-driven information to determine how to treat a patient. With these tests, providers are better able to understand what should and should not be prescribed to patients, mitigating the overuse of antimicrobials in this context.
Biomeme works in conjunction with WHO, the CDC, the FDA, and other federal organizations to achieve One Health. Without these collaborations, a better global health would be impossible.
table of contents
With the results of the AMR Challenge quickly approaching, we wanted to take a moment to reflect on our amazing team’s...